CA3153004A1 - Granule having masked unpleasant taste and method for producing same - Google Patents
Granule having masked unpleasant taste and method for producing same Download PDFInfo
- Publication number
- CA3153004A1 CA3153004A1 CA3153004A CA3153004A CA3153004A1 CA 3153004 A1 CA3153004 A1 CA 3153004A1 CA 3153004 A CA3153004 A CA 3153004A CA 3153004 A CA3153004 A CA 3153004A CA 3153004 A1 CA3153004 A1 CA 3153004A1
- Authority
- CA
- Canada
- Prior art keywords
- active ingredient
- particle
- granule
- unpleasant taste
- ethylcellulose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019-173744 | 2019-09-25 | ||
| JP2019173744 | 2019-09-25 | ||
| PCT/JP2020/035883 WO2021060304A1 (ja) | 2019-09-25 | 2020-09-24 | 不快な味がマスクされた顆粒剤及びその製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3153004A1 true CA3153004A1 (en) | 2021-04-01 |
Family
ID=75164923
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3153004A Pending CA3153004A1 (en) | 2019-09-25 | 2020-09-24 | Granule having masked unpleasant taste and method for producing same |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230016901A1 (https=) |
| EP (1) | EP4035733A4 (https=) |
| JP (3) | JP6905781B1 (https=) |
| CN (1) | CN114340601A (https=) |
| AU (1) | AU2020352037A1 (https=) |
| CA (1) | CA3153004A1 (https=) |
| TW (1) | TWI865615B (https=) |
| WO (1) | WO2021060304A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020352037A1 (en) * | 2019-09-25 | 2022-04-21 | Nobelpharma Co., Ltd. | Granule having masked unpleasant taste and method for producing same |
| TR2022010921A2 (tr) * | 2022-07-01 | 2024-01-22 | Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi | Tadı maskelenmiş bir çinko katı bileşimi. |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2542122B2 (ja) * | 1990-04-18 | 1996-10-09 | 旭化成工業株式会社 | 球状核、球形顆粒およびその製造方法 |
| JP3985907B2 (ja) | 1996-01-18 | 2007-10-03 | 旭化成ケミカルズ株式会社 | フィルムコーティング粒剤の製造方法 |
| JP2000053563A (ja) | 1998-08-07 | 2000-02-22 | Bayer Yakuhin Ltd | 苦味がマスクされた速放性細粒剤 |
| KR101168189B1 (ko) * | 2003-10-29 | 2012-07-25 | 시오노기세이야쿠가부시키가이샤 | 불쾌미를 개선한 피복 제제의 제조 방법 |
| CN102048734B (zh) * | 2005-05-26 | 2013-11-20 | 大日本住友制药株式会社 | 药物组合物 |
| JP2007031292A (ja) * | 2005-07-22 | 2007-02-08 | Hamari Chemicals Ltd | 亜鉛化合物含有組成物およびその製造方法 |
| JP5271081B2 (ja) * | 2006-07-26 | 2013-08-21 | 旭化成ケミカルズ株式会社 | 球形素顆粒およびその製造方法 |
| JP2008081448A (ja) * | 2006-09-28 | 2008-04-10 | Kowa Pharmaceutical Co Ltd | 酒石酸ゾルピデムの苦味マスキング速放性粒子 |
| EP2486917B1 (en) * | 2009-10-09 | 2020-11-25 | Asahi Kasei Kabushiki Kaisha | Coating film, and granules and tablets each utilizing same |
| AU2010325746B2 (en) * | 2009-12-02 | 2016-02-25 | Adare Pharmaceuticals S.R.L. | Fexofenadine microcapsules and compositions containing them |
| CN102018658B (zh) * | 2010-07-16 | 2014-03-12 | 钟术光 | 一种控释制剂及其制备方法 |
| JP5823401B2 (ja) * | 2010-09-13 | 2015-11-25 | 大鵬薬品工業株式会社 | 不快な味が遮蔽された薬物含有膜被覆粒子 |
| AU2020352037A1 (en) * | 2019-09-25 | 2022-04-21 | Nobelpharma Co., Ltd. | Granule having masked unpleasant taste and method for producing same |
-
2020
- 2020-09-24 AU AU2020352037A patent/AU2020352037A1/en active Pending
- 2020-09-24 CN CN202080059661.5A patent/CN114340601A/zh active Pending
- 2020-09-24 JP JP2021503619A patent/JP6905781B1/ja active Active
- 2020-09-24 US US17/642,107 patent/US20230016901A1/en active Pending
- 2020-09-24 WO PCT/JP2020/035883 patent/WO2021060304A1/ja not_active Ceased
- 2020-09-24 CA CA3153004A patent/CA3153004A1/en active Pending
- 2020-09-24 EP EP20867214.7A patent/EP4035733A4/en active Pending
- 2020-09-25 TW TW109133372A patent/TWI865615B/zh active
-
2021
- 2021-06-21 JP JP2021102118A patent/JP7715378B2/ja active Active
-
2025
- 2025-05-14 JP JP2025081181A patent/JP2025107467A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4035733A1 (en) | 2022-08-03 |
| CN114340601A (zh) | 2022-04-12 |
| TWI865615B (zh) | 2024-12-11 |
| JPWO2021060304A1 (ja) | 2021-10-07 |
| JP6905781B1 (ja) | 2021-07-21 |
| WO2021060304A1 (ja) | 2021-04-01 |
| TW202128143A (zh) | 2021-08-01 |
| JP2025107467A (ja) | 2025-07-17 |
| US20230016901A1 (en) | 2023-01-19 |
| EP4035733A4 (en) | 2024-01-10 |
| AU2020352037A1 (en) | 2022-04-21 |
| JP2021138775A (ja) | 2021-09-16 |
| JP7715378B2 (ja) | 2025-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2539982C (en) | Pantoprazole multiparticulate formulations | |
| RU2428176C2 (ru) | Системы доставки лекарственного средства, содержащие слабоосновные лекарственные средства и органические кислоты | |
| RU2490012C2 (ru) | Системы доставки лекарственного средства, содержащие слабощелочной селективный 5-ht3, серотониновый блокатор и органические кислоты | |
| JP2000281564A (ja) | 医薬製剤 | |
| BG65306B1 (bg) | Лекарствена форма с контролирано освобождаване, съдържаща галантамин | |
| JPH0237327B2 (https=) | ||
| EP3981390B1 (en) | Lacosamide pharmaceutical composition and pharmaceutical preparation thereof | |
| KR20090029830A (ko) | 소장 내에서 활성성분의 방출이 제어되는 경구투여용 약제학적 조제물 및 그의 제조방법 | |
| JP2025107467A (ja) | 不快な味がマスクされた顆粒剤及びその製造方法 | |
| JP2002531395A (ja) | 医薬合剤 | |
| CN105982858A (zh) | 一种阿奇霉素掩味的干混悬颗粒剂及其制备方法 | |
| CA2823622C (en) | Solid molecular dispersion of fesoterodine | |
| JP3833314B2 (ja) | 発泡性組成物およびその製造方法 | |
| CN103096880B (zh) | 不愉快味道被掩蔽的含药膜包覆的颗粒 | |
| CN105919943A (zh) | 一种盐酸可乐定控释颗粒及其制备方法 | |
| JPWO2002034268A1 (ja) | 5−アセチル−4,6−ジメチル−2−[2−[4−(2−メトキシフェニル)ピペラジニル]エチルアミノ]ピリミジン・三塩酸塩を有効成分として含有する徐放性製剤 | |
| HK40068436A (en) | Granule having masked unpleasant taste and method for producing same | |
| JPH04103525A (ja) | 難水溶性薬物の持続性製剤化方法 | |
| NZ535372A (en) | An improved modified release preparation | |
| JPH09169645A (ja) | イブジラスト含有持続性製剤およびその製法 | |
| CN114272233A (zh) | 一种奥司他韦组合物及其制备方法 | |
| JP2008050324A (ja) | 苦味遮蔽組成物。 | |
| CA3013429C (en) | Prolonged release pharmaceutical composition comprising cysteamine or salt thereof | |
| CN110664779A (zh) | 一种头孢呋辛酯颗粒及其制备方法 | |
| JPH05163163A (ja) | 有核製剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240909 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20240909 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240909 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20241025 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20241025 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20241115 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250407 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20250430 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD Year of fee payment: 5 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250826 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250826 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20250903 |
|
| B12 | Application deemed to be withdrawn, abandoned or lapsed |
Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B12-B303 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO AN EXAMINER'S REQUISITION Effective date: 20260105 |